Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epicardial adipose tissue signatures in Asian coronary artery disease: Insights from cardiac CT.

American journal of preventive cardiology·2026
Same author

Genomic landscape of drug binding and pharmacogenetic variation across diverse populations using SNPdrug3D.

Nature communications·2026
Same author

TP53 mutation at codon 179 metabolically reprograms cancer cells to promote invasion.

Cancer gene therapy·2026
Same author

DiffBulk: Enhancing Spatial Transcriptomic Prediction With Diffusion-Based Training.

IEEE transactions on medical imaging·2026
Same author

Can 3D T1 Post-Contrast MRI in A Radiomics-Machine Learning Model Distinguish Infective from Neoplastic Ring-Enhancing Brain Lesions? An Exploratory Study.

Diagnostics (Basel, Switzerland)·2026
Same author

Discovery of Pan-TEAD Inhibitors That Disrupt YAP-TEAD Interaction as a Potential Therapy for Gastric Cancers and Mutant KRAS and EGFR Lung Cancers.

ACS medicinal chemistry letters·2026

Related Experiment Video

Updated: Sep 9, 2025

Author Spotlight: Advancing Cell Membrane Biophysics - Exploring Interactions and Challenges Through Experimental and Computational Approaches
07:31

Author Spotlight: Advancing Cell Membrane Biophysics - Exploring Interactions and Challenges Through Experimental and Computational Approaches

Published on: September 1, 2023

2.5K

Systematic benchmarking of 13 AI methods for predicting cyclic peptide membrane permeability.

Wei Liu1, Jianguo Li2,3, Chandra S Verma2,4,5

  • 1Bioinformatics Institute, Agency for Science, Technology and Research, 30 Biopilis Street, Singapore, 138671, Singapore. liuwei@bii.a-star.edu.sg.

Journal of Cheminformatics
|August 28, 2025
PubMed
Summary

Machine learning models can predict cyclic peptide membrane permeability, aiding drug discovery. Graph-based models like DMPNN show the best performance, improving the identification of cell-permeable drug candidates.

Keywords:
Benchmark studyCyclic peptideDeep learningMembrane permeability prediction

More Related Videos

High-throughput Measurement of Plasma Membrane Resealing Efficiency in Mammalian Cells
10:07

High-throughput Measurement of Plasma Membrane Resealing Efficiency in Mammalian Cells

Published on: January 7, 2019

7.9K
Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers
10:12

Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers

Published on: September 19, 2022

2.2K

Related Experiment Videos

Last Updated: Sep 9, 2025

Author Spotlight: Advancing Cell Membrane Biophysics - Exploring Interactions and Challenges Through Experimental and Computational Approaches
07:31

Author Spotlight: Advancing Cell Membrane Biophysics - Exploring Interactions and Challenges Through Experimental and Computational Approaches

Published on: September 1, 2023

2.5K
High-throughput Measurement of Plasma Membrane Resealing Efficiency in Mammalian Cells
10:07

High-throughput Measurement of Plasma Membrane Resealing Efficiency in Mammalian Cells

Published on: January 7, 2019

7.9K
Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers
10:12

Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers

Published on: September 19, 2022

2.2K

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Machine learning

Background:

  • Cyclic peptides are valuable drug candidates for modulating protein-protein interactions.
  • Poor membrane permeability hinders their therapeutic use.
  • Computational prediction of permeability can streamline drug development.

Purpose of the Study:

  • To benchmark machine learning models for predicting cyclic peptide membrane permeability.
  • To evaluate different molecular representations and model architectures.
  • To assess prediction performance across regression and classification tasks.

Main Methods:

  • Evaluated 13 machine learning models using diverse molecular representations (fingerprints, SMILES, graphs, images).
  • Utilized PAMPA permeability data for nearly 6000 cyclic peptides from the CycPeptMPDB database.
  • Employed random and scaffold splitting strategies to assess model generalizability.

Main Results:

  • Model performance varied significantly based on molecular representation and architecture.
  • Graph-based models, especially Directed Message Passing Neural Network (DMPNN), demonstrated superior performance.
  • Regression tasks generally yielded better results than classification tasks.
  • Scaffold splitting indicated lower generalizability than random splitting.

Conclusions:

  • Machine learning, particularly graph-based approaches, shows promise for predicting cyclic peptide permeability.
  • Current models offer practical value but further improvements are needed.
  • Understanding model generalizability is crucial for reliable predictions.